Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vincent Rajkumar

Showing results (301-310 of 566) with videos related to

Pageof 57
Sort By:
Bone Marrow Transplantation|June 11, 2020
Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosisNadine Abdallah, Surbhi Sidana, Angela Dispenzieri, et al.
NPJ Precision Oncology|April 14, 2026
Proteomic profiling revealed unique disease biology associated with 1q abnormalities in multiple myelomaKiran K Mangalaparthi, Joel-Sean Hsu, J Erin Wiedmeier-Nutor, et al.
The Lancet. Haematology|December 28, 2020
Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trialSaad Z Usmani, Antje Hoering, Sikander Ailawadhi, et al.
Frontiers in Oncology|June 1, 2022
Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like CellsHarish Kumar, Suman Mazumder, Neeraj Sharma, et al.
Blood Cancer Journal|November 27, 2021
Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosisAlissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
American Journal of Hematology|June 16, 2011
High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, AfricaFrancis Buadi, Ann W Hsing, Jerry A Katzmann, et al.
Mayo Clinic Proceedings|May 20, 2014
Remission of disseminated cancer after systemic oncolytic virotherapyStephen J Russell, Mark J Federspiel, Kah-Whye Peng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosisAngela Dispenzieri, Morie A Gertz, Robert A Kyle, et al.
Cancer|October 6, 2005
Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myelomaJames R Berenson, Sundar Jagannath, Bart Barlogie, et al.
Blood|August 28, 2010
Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical featuresShaji Kumar, Angela Dispenzieri, Jerry A Katzmann, et al.
Pageof 57

Showing results (301-310 of 566) with videos related to

Sort By:
Pageof 57
Bone Marrow Transplantation|June 11, 2020
Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosisNadine Abdallah, Surbhi Sidana, Angela Dispenzieri, et al.
NPJ Precision Oncology|April 14, 2026
Proteomic profiling revealed unique disease biology associated with 1q abnormalities in multiple myelomaKiran K Mangalaparthi, Joel-Sean Hsu, J Erin Wiedmeier-Nutor, et al.
The Lancet. Haematology|December 28, 2020
Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trialSaad Z Usmani, Antje Hoering, Sikander Ailawadhi, et al.
Frontiers in Oncology|June 1, 2022
Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like CellsHarish Kumar, Suman Mazumder, Neeraj Sharma, et al.
Blood Cancer Journal|November 27, 2021
Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosisAlissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
American Journal of Hematology|June 16, 2011
High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, AfricaFrancis Buadi, Ann W Hsing, Jerry A Katzmann, et al.
Mayo Clinic Proceedings|May 20, 2014
Remission of disseminated cancer after systemic oncolytic virotherapyStephen J Russell, Mark J Federspiel, Kah-Whye Peng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosisAngela Dispenzieri, Morie A Gertz, Robert A Kyle, et al.
Cancer|October 6, 2005
Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myelomaJames R Berenson, Sundar Jagannath, Bart Barlogie, et al.
Blood|August 28, 2010
Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical featuresShaji Kumar, Angela Dispenzieri, Jerry A Katzmann, et al.
Pageof 57